Imperial College Hospitals are the five hospitals of Imperial College London Healthcare NHS Trust: St Mary's Hospital, Charing Cross Hospital, Hammersmith Hospital, Queen Charlotte's and Chelsea Hospital and Western Eye Hospital. Hammersmith Hospital, Queen Charlotte's and Chelsea Hospital and Western Eye Hospital.
St. Luke's International Hospital was established in 1901 and has been in operation for over a century. The hospital still adheres to the philosophy of its founder, the American missionary and doctor Rudolf Bolling Teusler: "The Christian heart of love can remove people's worries, relieve their pain and make them feel like new creatures. In order to bring this great power to all patients, I have created such a vibrant hospital."
Leukaemia is a very complex disease that causes fever and infection and bleeding, so it needs to be treated early so that it can be gradually controlled and the patient's symptoms can be gradually relieved
Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.
Everyone wants to be in good health because we all know that good health is the only way to live a better life. However, many diseases still occur frequently nowadays, so we need to know about the common diseases
Christie Hospital, based in Manchester, is one of the top three cancer centres in Europe, with 2,500 staff, 300 volunteers and 30,000 members, treating over 44,000 patients each year
UniversityClinic Hamburg-Eppendorf, UKE was founded on 17 May 1889 in Hamburg, Germany's second largest city, and is one of Europe's leading hospitals and the NO.1 medical centre of its size in Hamburg.
The results of a new study recently showed that Olutasidenib monotherapy in patients with relapsed/refractory acute myeloid leukaemia carrying the IDH1 mutation elicited high rates of complete remission with manageable toxicity.
The US FDA has approved a new leukaemia drug, Olutasidenib, which has been shown to be effective and has a controlled safety profile, resulting in the complete disappearance of cancer cells in 35% of patients enrolled, with efficacy lasting up to 25.9 months.
Duke University Hospital conceptually integrates the Duke University Health System, the Duke University School of Medicine and the Duke University School of Nursing. It is a combination of research, clinical care and education through the efforts of all practitioners. Located in North Carolina, the 819-bed tertiary care hospital is a key affiliate of the Duke University Health System.
